Intellectual Capital and Competitive Advantages: The Case of Tty Biopharm Company

Journal of Business Chemistry, Vol. 1, No. 1, 2004

7 Pages Posted: 21 Jul 2005

See all articles by Ming-Chin Chen

Ming-Chin Chen

National Chengchi University (NCCU) - Department of Accounting

Abstract

By conducting indepth interviews with CEO and top management of TTY Biopharm Company, a Taiwan-based pharmaceutical company, I depict the role of TTY's intellectual capital in building competitive advantages and enhancing the achievement of corporate strategies. TTY's success illustrates that even in a relatively small pharmaceutical market such as Taiwan, where a full-range new drug R&D, covering from discovering new chemicals to developing new drugs, seems economically infeasible, adopting fit R&D strategies and developing intellectual capital to establish competitive advantages can overcome the limitations in home market size and bear fruitful results.

Suggested Citation

Chen, Ming-Chin, Intellectual Capital and Competitive Advantages: The Case of Tty Biopharm Company. Journal of Business Chemistry, Vol. 1, No. 1, 2004, Available at SSRN: https://ssrn.com/abstract=757684

Ming-Chin Chen (Contact Author)

National Chengchi University (NCCU) - Department of Accounting ( email )

No. 64, Sec 2
Chih-Nan Road
Wenshan, Taipei
Taiwan

Do you have a job opening that you would like to promote on SSRN?

Paper statistics

Downloads
465
Abstract Views
2,101
rank
77,154
PlumX Metrics